Replies to Post #421 onBristol Myers Squibb (BMY)

Replies to post #421 on Bristol Myers Squibb (BMY)

Replies to #421 on Bristol Myers Squibb (BMY)

01/26/17 1:23 PM

#424 RE: DewDiligence #421

mostly agree. story coming shortly.
— Charley Grant (@CGrantWSJ) January 26, 2017

07/01/17 12:22 PM

#543 RE: DewDiligence #421

Barron’s likes BMY for same reasons I do: #msg-132662515.